Unknown

Dataset Information

0

SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling.


ABSTRACT: SOX9 inactivation is frequent in colorectal cancer (CRC) due to SOX9 gene mutations and/or to ectopic expression of MiniSOX9, a dominant negative inhibitor of SOX9. In the present study, we report a heterozygous L142P inactivating mutation of SOX9 in the DLD-1 CRC cell line and we demonstrate that the conditional expression of a wild type SOX9 in this cell line inhibits cell growth, clonal capacity and colonosphere formation while decreasing both the activity of the oncogenic Wnt/ß-catenin signaling pathway and the expression of the c-myc oncogene. This activity does not require SOX9 transcriptional function but, rather, involves an interaction of SOX9 with nuclear ß-catenin. Furthermore, we report that SOX9 inhibits tumor development when conditionally expressed in CRC cells injected either subcutaneous or intraperitoneous in BALB/c mice as an abdominal metastasis model. These observations argue in favor of a tumor suppressor activity for SOX9. As an siRNA targeting SOX9 paradoxically also inhibits DLD-1 and HCT116 CRC cell growth, we conclude that there is a critical level of endogenous active SOX9 needed to maintain CRC cell growth.

SUBMITTER: Prevostel C 

PROVIDER: S-EPMC5347687 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling.

Prévostel Corinne C   Rammah-Bouazza Cyrine C   Trauchessec Hélène H   Canterel-Thouennon Lucile L   Busson Muriel M   Ychou Marc M   Blache Philippe P  

Oncotarget 20161201 50


SOX9 inactivation is frequent in colorectal cancer (CRC) due to SOX9 gene mutations and/or to ectopic expression of MiniSOX9, a dominant negative inhibitor of SOX9. In the present study, we report a heterozygous L142P inactivating mutation of SOX9 in the DLD-1 CRC cell line and we demonstrate that the conditional expression of a wild type SOX9 in this cell line inhibits cell growth, clonal capacity and colonosphere formation while decreasing both the activity of the oncogenic Wnt/ß-catenin signa  ...[more]

Similar Datasets

| S-EPMC5348345 | biostudies-literature
| S-EPMC3959627 | biostudies-literature
| S-EPMC10643375 | biostudies-literature
| S-EPMC4406530 | biostudies-literature
| S-EPMC5707165 | biostudies-literature
| S-EPMC3515623 | biostudies-literature
| S-EPMC6974163 | biostudies-literature
| S-EPMC6537088 | biostudies-literature
| S-EPMC5312301 | biostudies-literature
| S-EPMC6763786 | biostudies-literature